Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omeprazole on Nelfinavir PK
NCT00251030Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nelfinavir in human immunodeficiency virus infection (HIV), sponsored by Pfizer. Primary endpoint: Pharmacokinetics of Nelfinavir and M8 at Day 4. Started Nov 2005; status: completed.
02
Drugs
nelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00251030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251030.